Insider · CIK 0001859509
Benjamin Looker
officer
Files at ESPR (Esperion Therapeutics, Inc.). First filing Jun 18, 2025, latest Mar 18, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 7
$0 bought, $74k sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | Esperion Therapeutics, Inc. | $15k 5,708 shares | -1% | - | |
| 15Weak | ESPRsell Esperion Therapeutics, Inc. | $4,868 1,689 shares | -0% | - | |
| 30Weak | Esperion Therapeutics, Inc. | $24k 6,517 shares | -2% | - | |
| 15Weak | ESPRsell Esperion Therapeutics, Inc. | $3,275 1,248 shares | -0% | - | |
| 30Weak | Esperion Therapeutics, Inc. | $18k 6,267 shares | -2% | - | |
| 23Weak | Esperion Therapeutics, Inc. | $1,470 1,304 shares | -0% | - | |
| 30Weak | Esperion Therapeutics, Inc. | $7,398 6,422 shares | -2% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 17, 2026 | ESPR Esperion Therapeutics, Inc. | SOpen-market sale Common Stock | -5,708 | $2.70 | $15k | 679,348 | Mar 18, 2026 |
| Mar 13, 2026 | ESPR Esperion Therapeutics, Inc. | AGrant or award Common Stock | +300,840 | $0.00 | $0 | 685,056 | Mar 16, 2026 |
| Mar 13, 2026 | ESPR Esperion Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +269,230 | $0.00 | $0 | 269,230 | Mar 16, 2026 |
| Jan 20, 2026 | ESPR Esperion Therapeutics, Inc. | SOpen-market sale Common Stock | -1,689 | $2.88 | $4,868 | 384,216 | Jan 21, 2026 |
| Dec 17, 2025 | ESPR Esperion Therapeutics, Inc. | SOpen-market sale Common Stock | -6,517 | $3.67 | $24k | 385,905 | Dec 18, 2025 |
| Oct 17, 2025 | ESPR Esperion Therapeutics, Inc. | SOpen-market sale Common Stock | -1,248 | $2.62 | $3,275 | 392,422 | Oct 20, 2025 |
| Sep 17, 2025 | ESPR Esperion Therapeutics, Inc. | SOpen-market sale Common Stock | -6,267 | $2.80 | $18k | 393,670 | Sep 18, 2025 |
| Jul 17, 2025 | ESPR Esperion Therapeutics, Inc. | SOpen-market sale Common Stock | -1,304 | $1.13 | $1,470 | 399,937 | Jul 18, 2025 |
| Jun 17, 2025 | ESPR Esperion Therapeutics, Inc. | SOpen-market sale Common Stock | -6,422 | $1.15 | $7,398 | 401,241 | Jun 18, 2025 |
| Mar 14, 2025 | ESPR Esperion Therapeutics, Inc. | AGrant or award Common Stock | +224,000 | $0.00 | $0 | 407,663 | Mar 17, 2025 |
| Mar 14, 2025 | ESPR Esperion Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +201,000 | $0.00 | $0 | 201,000 | Mar 17, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.